Conclusion: Our findings indicate that LINC00355:8 activates Wnt10b and promotes HCC progression via the suppression of miR-6777-3p, which may provide novel therapeutic targets for HCC. The gene discussed is WNT10B; the disease is hepatocellular carcinoma.